Moreover, alpha-fetoprotein (AFP), which is a representable liver cancer biomarker, has reported poor diagnostic performance20; thus, the reliability of current liver cancer biomarkers are being questioned in clinical settings. This evidence concerns the gene AFP and liver cancer.